Belano, Analie T.
HRN: 19-06-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
CEFUROXIME 500MG (TAB)
02/02/2023
02/09/2023
PO
500mg
BID
2nd Degree RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes